Cite
Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).
MLA
Bauermeister, José A., et al. “Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).” AIDS Education & Prevention, vol. 33, no. 5, Oct. 2021, pp. 361–76. EBSCOhost, https://doi.org/10.1521/aeap.2021.33.5.361.
APA
Bauermeister, J. A., Tingler, R. C., Johnson, S., Macagna, N., Lucas, J., Dominguez-Islas, C., Szydlo, D., Ngo, J., Jacobson, C. E., Kramzer, L., Singh, D., Dezzutti, C. S., Kunjara Na Ayudhya, R. P., Piper, J., Devlin, B., Hendrix, C. W., & Ho, K. (2021). Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study). AIDS Education & Prevention, 33(5), 361–376. https://doi.org/10.1521/aeap.2021.33.5.361
Chicago
Bauermeister, José A., Ryan C. Tingler, Sherri Johnson, Nicole Macagna, Jonathan Lucas, Clara Dominguez-Islas, Daniel Szydlo, et al. 2021. “Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).” AIDS Education & Prevention 33 (5): 361–76. doi:10.1521/aeap.2021.33.5.361.